Hotline: new coronary devices (DES, BRS, DCB)

Anchorperson: R. Byrne

Spokesperson: R. Kornowski

Summary

This hotline session provides a comprehensive overview of the latest clinical data on new coronary devices, including bioresorbable scaffolds, drug-coated balloons, and drug-eluting stents. Participants will learn about the outcomes of various randomized trials and registry studies, examining the performance of these innovative technologies in different patient populations and clinical scenarios.

Presentations available when logged in:

A randomised trial of iron bioresorbable scaffold compared with XIENCE in coronary artery disease
Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes
Two-year clinical outcomes of the BIOADAPTOR RCT study
Results of the magnesium BRS in complex lesions: data from the IT-Masters registry
Randomised trial of biolimus vs paclitaxel coated balloons for coronary in-stent restenosis
Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study
Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes...
Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Hotline: new coronary devices (DES, BRS, DCB)

Log in or create account for free